Bose has achieved results in promoting drug reform, and the people's sense of gain has gradually increased

Since 2019, the Baise Municipal Medical Security Bureau has been actively deepening the supply-side reform of medical services in accordance with the unified deployment of the state and the autonomous region, continuously promoting the normalization and institutionalization of pharmaceutical prices to carry out centralized procurement of drugs and medical consumables, and successively organized public medical institutions and non-public medical institutions in the city to actively participate in six batches such as the pilot expansion of centralized procurement and use of drugs organized by the state to expand 4+7, Guangxi organized negotiations for the second batch, and the interprovincial alliance launched seven batches of hanging nets.
A total of 15 batches of 712 varieties of thousands of specifications of drugs have been purchased in centralized quantities, and the contract signing rate has reached 96%.

According to the statistics of the centralized procurement platform, as of November 2022, the city has completed a total of 48,000 drug contract signings, completed the purchase amount of 650 million yuan, estimated that the average reduction of drugs has reached 56%, saved 828 million yuan in procurement costs in contracts, saved 328 million yuan in economic burden for patients, and released 500 million yuan
for the medical insurance fund 。 The city completed the signing and procurement of medical consumables contracts with a purchase amount of 70 million yuan, which was reduced by 80% according to the average purchase of various consumables, and it is estimated that contract signing can save procurement costs of 350 million yuan, calculated according to the average reimbursement ratio of 45-60% of the medical insurance fund, which can save 175 million yuan in economic burden for patients and release 175 million yuan
for the medical insurance fund.
Among them, the average price of medical high-value consumables coronary stent was reduced by 93.
68%, the average price of artificial hip and knee joints was reduced by 82%, the average reduction of intraocular lenses was 70%, and the average reduction of testing reagents was more than 90%, and medical reform achieved obvious results
.

Since participating in the procurement of pharmaceutical groups, the city has completed the signing of drug contracts and procurement amounts of 650 million yuan, an average reduction of 56%, saving procurement costs of 828 million yuan, and reducing the economic burden of patients by 328 million yuan
according to the reimbursement ratio of the medical insurance fund policy.
Most of the pharmaceutical reform is to include drugs for common diseases and chronic diseases into centralized procurement, and the price reduction is relatively large
.
The price of entecavir for the treatment of hepatitis B decreased from 12.
10 yuan to 0.
2746 yuan, a decrease of 97.
73%; metformin, a commonly used drug for the treatment of diabetes, decreased by 87.
62%; Meloxicam tablets, the original drug for the treatment of rheumatoid arthritis, decreased by 80.
64%, and the monthly drug expenditure of patients dropped from 150.
8 yuan to 29.
4 yuan
based on the daily dosage of 2 tablets.
By organizing and carrying out centralized procurement of drugs, drug prices have been continuously reduced, while medical institutions have strictly implemented zero-difference drug sales and implemented the policy of medical insurance payment at selected prices, effectively reducing the economic burden of patients with medicine, and gradually enhancing the
people's gains.

Since participating in the pharmaceutical group's procurement in volume for three years, the city's drug and consumables signed procurement contracts have increased year by year, the year-on-year growth rate of procurement varieties and procurement funds has exceeded 50%, and a total of 675 million yuan of medical insurance funds have been released, which has greatly eased the pressure on the city's medical insurance fund and improved the efficiency of the use of
medical insurance funds.

In addition, the incentive policy of Baise Medical Security Bureau has been implemented to promote the enthusiasm of
medical institutions for centralized procurement.
Since the launch of the centralized procurement of medicine in September 2019, the Baise Municipal Medical Security Bureau has gone from insufficient understanding and low enthusiasm for centralized procurement to the implementation of the incentive policy for retaining the balance of medical insurance funds in centralized procurement of 17.
8 million yuan, and the leaders of medical institutions and medical staff of departments have gradually improved their understanding of centralized procurement work, promoted medical institutions to expand centralized procurement, and improved the enthusiasm
of centralized procurement work 。 The work results range from purchasing 104 landing varieties in 2020 with a signed procurement contract amount of 56 million yuan, to purchasing 333 landing varieties in 2021 with a signed procurement contract amount of 250 million yuan, and then purchasing 686 landing varieties in 2022, with a signed procurement contract amount of 350 million yuan, with a significant
increase year by year.

In the next step, the Baise Medical Security Bureau will increase the publicity of the centralized procurement policy, continue to rationalize the procurement management mechanism of the pharmaceutical consumables group, implement the regulatory duties, standardize the procurement behavior and supervision of pharmaceutical consumables in medical institutions, better serve the people, and continuously improve the sense of gain, security and happiness of the masses
.